Ensysce Biosciences, Inc. (ENSC) Financials
ENSC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 2.2 million | 2.8 million |
| Dec. 31, 2025 | 7.5 million | 4.6 million |
| Sept. 30, 2025 | 3.2 million | 2.3 million |
| June 30, 2025 | 5.6 million | 2.5 million |
ENSC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -3.5 million | 8743 |
| Dec. 31, 2025 | -1.5 million | 249107 |
| Sept. 30, 2025 | -2.0 million | 96576 |
| June 30, 2025 | -2.7 million | 156921 |
ENSC Net Income
No data available :(
ENSC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 745482 | - | - |
| Dec. 31, 2025 | 4.3 trillion | - | - |
| Sept. 30, 2025 | 1.7 million | - | - |
| June 30, 2025 | 2.2 million | - | - |
ENSC Shares Outstanding
ENSC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 3.3 million | 1.2 million | - |
| Dec. 31, 2025 | 123640 | 3.6 million | 1.1 million | - |
| Sept. 30, 2025 | 123643 | 3.0 million | 1.3 million | - |
| June 30, 2025 | - | 1.9 million | 1.2 million | - |
ENSC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 960999 | 6533 |
| Dec. 31, 2025 | 1.9 million | - |
| Sept. 30, 2025 | 493104 | 3.0 million |
| June 30, 2025 | 1.4 million | 1.9 million |
ENSC Revenue by Segment
Graph available only for paid members. Upgrade to see it.
ENSC
Price: $0.27
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.11 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 86482
Market Capitalization: 2.4 million